Skip to main content

Table 1 Serotype distribution, demography and comorbidities of DENV infected patients

From: Impact of dengue virus (DENV) co-infection on clinical manifestations, disease severity and laboratory parameters

Characteristics

N (%)

DENV serotypes

 

Mono-infection

222 (84.7)

 DENV-1

170 (76.6)

 DENV-2

44 (19.8)

 DENV-3

7 (3.2)

 DENV-4

1 (0.5)

Co-infection

40 (15.3)

 DENV-1/DENV-2

34 (85)

 DENV-1/DENV-3

5 (12.5)

 DENV-2/DENV-3

1 (2.5)

Race

 

 Malay

157 (59.9)

 Chinese

34 (13)

 Indian

29 (11.1)

 Foreign workers

37 (14.1)

 Others

5 (1.9)

 Male

146 (55.7)

Age groups

 

 <18

38 (14.5)

 18-29

104 (39.7)

 30-39

64 (24.4)

 40-49

27 (10.3)

 50-59

17 (6.5)

 >60

12 (4.6)

 Pregnancy

14 (5.3)

Comorbiditiesa

52 (19.8)

 Diabetes mellitus

21 (8)

 Hypertension

15 (5.7)

 Asthma

14 (5.3)

 Cardiovascular disease

6 (2.3)

 Blood disorderb

4 (1.5)

 Malignancyc

4 (1.5)

 Psychiatric disorders

4 (1.5)

 Othersd

5 (1.9)

  1. aA patient may have more than one comorbidities
  2. bIncludes G6PD deficiency (n = 2), beta-thalassaemia (n = 1), von Willebrand disease (n = 1)
  3. cIncludes cancer of breast (n = 1), ear (n = 1), pancreas (n = 1), ovary (n = 1)
  4. dOne patient each had- chronic obstructive airway disease, military tuberculosis, splenectomy, end stage renal failure, systemic lupus erythematosus